Our Pricing

What to Expect from Mounjaro Sulphur Burps Over Time

Published on: June 03, 2026

Understanding the mounjaro sulphur burps timeline UK patients experience can help you manage this common side effect with confidence. Sulphur burps—characterised by a distinct rotten egg odour—affect approximately 15-20% of tirzepatide users during treatment initiation, typically emerging within the first 2-4 weeks and resolving as your body adapts to the medication [1].

Why Mounjaro Causes Sulphur Burps: The Science Behind the Side Effect

Mounjaro (tirzepatide) works by activating both GIP and GLP-1 receptors, which significantly slow gastric emptying—the rate at which food moves from your stomach into your small intestine [1]. This delayed emptying is part of how the medication reduces appetite and promotes weight loss, but it also creates an environment where hydrogen sulphide gas can accumulate.

When food remains in your stomach longer than usual, gut bacteria have extended time to break down proteins containing sulphur-rich amino acids like methionine and cysteine. This bacterial fermentation produces hydrogen sulphide, the same compound responsible for the characteristic rotten egg smell [2]. The effect is most pronounced during dose escalation periods when your digestive system is still adjusting to the medication's gastrointestinal effects.

Clinical data from the SURPASS trials showed that gastrointestinal side effects, including sulphur burps, were most common during the first 8-12 weeks of treatment and typically decreased significantly as patients continued therapy [1]. Understanding this mechanism helps explain why certain dietary modifications can be particularly effective in managing symptoms.

Week-by-Week Timeline: When Mounjaro Sulphur Burps Start, Peak, and Resolve

The timeline for sulphur burps varies considerably between individuals, but clinical experience reveals consistent patterns across most patients taking tirzepatide. Recognising these phases helps you anticipate and manage symptoms effectively throughout your treatment journey.

Weeks 1-2: Initial Adjustment Phase

Most patients starting Mounjaro at the initial 2.5 mg dose experience minimal to no sulphur burps during the first fortnight. Your digestive system is beginning to adapt to the medication's effects on gastric emptying, but symptoms typically haven't yet manifested. If sulphur burps do occur this early, they're usually mild and intermittent, often triggered by high-protein or fatty meals.

Peak Symptom Period and Dose Escalation Effects

Weeks 3-8: Peak Occurrence Window

Sulphur burps typically peak between weeks 3 and 8 of Mounjaro treatment, particularly during dose increases from 2.5 mg to 5 mg, and again when escalating to 7.5 mg [1]. This period coincides with maximum gastric emptying delay as your body adjusts to higher tirzepatide concentrations. Patients report sulphur burps occurring most frequently 2-4 hours after meals, especially those containing red meat, eggs, or cruciferous vegetables.

During this phase, approximately 15-20% of patients experience noticeable sulphur burps, though severity varies widely. Some describe occasional episodes, whilst others report daily occurrences that temporarily affect quality of life. The good news: this represents the peak, and symptoms typically begin improving from week 8 onwards as your digestive system adapts to the medication's pharmacological effects [2].

Evidence-Based Strategies to Reduce Mounjaro Sulphur Burps

Managing sulphur burps doesn't require discontinuing Mounjaro. Clinical experience shows that targeted dietary adjustments, timing modifications, and over-the-counter remedies can substantially reduce symptoms whilst you continue benefiting from the medication's weight loss effects. These strategies work best when implemented consistently throughout the peak symptom period.

Dietary Modifications That Work

Reducing sulphur-rich foods during the peak symptom period can significantly decrease burp frequency and intensity. High-sulphur foods include red meat, eggs, poultry, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, onions, and certain dairy products. Substituting these with lower-sulphur alternatives like white fish, rice, bananas, and leafy greens often provides noticeable relief within 48-72 hours.

Eating smaller, more frequent meals rather than three large meals daily helps prevent food from sitting in your stomach for extended periods. Many patients find success with 4-5 smaller portions spread throughout the day, keeping individual meal sizes under 400 calories during the peak symptom window. Thorough chewing and eating slowly—taking at least 20 minutes per meal—further supports digestion and reduces bacterial fermentation time [2].

Long-Term Outlook: When Sulphur Burps Typically Resolve

Clinical data from long-term tirzepatide studies demonstrates that gastrointestinal side effects, including sulphur burps, show marked improvement with continued treatment. The SURPASS-3 trial reported that whilst 18% of participants experienced digestive symptoms during the first 12 weeks, only 4% reported ongoing issues at the 72-week endpoint [1]. This substantial decrease reflects genuine physiological adaptation rather than patients simply tolerating symptoms.

Weeks 12-16: Resolution Phase

Most patients experience significant improvement or complete resolution of sulphur burps between weeks 12 and 16 of continuous Mounjaro treatment [1]. Your digestive system has adapted to the medication's effects on gastric emptying, and the gut microbiome has adjusted to the altered digestive environment. Even patients who experienced pronounced symptoms during weeks 3-8 typically report minimal to no sulphur burps by month four.

For the small percentage of patients who continue experiencing symptoms beyond 16 weeks, they're usually much milder than during the peak period and occur less frequently. If sulphur burps persist severely after four months of treatment, your UK prescriber may consider adjusting your dose escalation schedule or exploring alternative weight loss medications like semaglutide, which some patients tolerate differently due to its single GLP-1 receptor mechanism [2].

Mounjaro Treatment Options and Clinical Support at Cured Pharmacy

At Cured Pharmacy, we provide Mounjaro (tirzepatide) KwikPen injections from £124.99, with transparent upfront pricing and no hidden consultation fees. Every prescription requires a clinical assessment by our UK-registered prescribers, who evaluate your medical history, current medications, and weight loss goals to determine if Mounjaro is appropriate for you. Our online consultation takes under three minutes and includes personalised guidance on managing potential side effects like sulphur burps.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), leads a clinical team experienced in supporting patients through GLP-1 treatment journeys. We offer alternative weight loss medications including Wegovy (semaglutide) and Saxenda (liraglutide) if Mounjaro isn't suitable or if side effects prove challenging to manage. All medications are UK-licensed, dispensed from our GPhC-registered pharmacy (9012511), and delivered in 100% discreet packaging.

If you experience persistent sulphur burps or other concerning symptoms whilst taking Mounjaro, our clinical team is available on (+44) 116 4646009 for guidance. We can arrange prescriber reviews to assess whether dose adjustment, slower escalation, or alternative treatments might better suit your needs. Starting your weight loss journey with proper clinical support significantly improves both outcomes and treatment tolerability.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
3. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
4. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
5. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine subject to prescriber approval based on individual medical suitability.